Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicenna Therapeutics Corp
T.MDNA
Alternate Symbol(s):
MDNAF
Healthcare
Biotechnology
Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company's principal business activity is the development and commercialization of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL...
-2 with superior CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity, thereby preferentially stimulating cancer-killing effector T cells and NK cells. The Company’s IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials including a Phase IIb trial for recurrent glioblastoma (GBM). The Company’s early-stage Bifunctional SuperKine ImmunoTherapies (BiSKITs) program Targeted Metalloprotease Activated SuperKine (T-MASK) programs are designed to enhance the ability of Superkines to treat immunologically cold tumors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MDNA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Feb 12, 2024 12:27pm
Strange price for a company that could easily
surrpass 10.00 US . Low float .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Feb 12, 2024 12:15pm
Slow motion , lets see a pop pop to .85
Don' t wait YWMO , VKTX 31.00 3 billion M/C , Weight loss drug , maybe .
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Feb 09, 2024 4:33pm
RE:Lets see a few million volume . Scotty take us up .
Let's see what Monday brings!
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Feb 09, 2024 2:13pm
Lets see a few million volume . Scotty take us up .
.
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Feb 09, 2024 1:33pm
Interesting
The signs are there
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Feb 09, 2024 12:45pm
I dream of the past when this ran over 7 $ on GBM data
now with Keytruda and two trials maybe 10 + $$$ .
(99)
•••
windymayor1
X
View Profile
View Bullboard History
Comment by
windymayor1
on Feb 09, 2024 11:03am
RE:RE:Thoughts?
On the move!
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Comment by
Galaxym31
on Feb 05, 2024 1:32pm
RE:Thoughts?
Always if results are positive . As for the GBM trial I always wondered why they did not try more than one treatment .
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Feb 02, 2024 3:30pm
Thoughts?
Buyout potential??
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Jan 31, 2024 8:50pm
PwC Resignation
Does anyone find it odd that their auditors resigned?
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Jan 18, 2024 11:30pm
Good risk reward at this price . IMO
$$$$
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Jan 05, 2024 2:27pm
I am framing my transaction statement for a
purchase of 2500 shares of MDNA at .235 CDN when we cross 10.00 $ .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Dec 27, 2023 8:21pm
Management must be optimistic to extend the warrant
excersise date , I can only hope .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Nov 19, 2023 4:22pm
There must be many people in the world that would welcome
a chance to manage this terminal disease not sure why big money has not stepped up to speed up this next trial . Rich people of all ages get this disease . Do it now get involved .
(580)
•••
Galaxym31
X
View Profile
View Bullboard History
Post by
Galaxym31
on Nov 19, 2023 3:29pm
Why only a single treatment for GBM .
..
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario